Deciphering the role of angiogenesis in glioblastoma: Integrative insights from transcriptomic profiling, single-cell sequencing and interpretable machine learning approaches
Pathology - Research and Practice · 2026
DOI: 10.1016/j.prp.2025.156305 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathology - Research and Practice, 2026. Verfasst von Fan Yang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pathology, Southwest Hospital, Third Military Medical University (Army Medical University), and Key Laboratory of Tumor Immunopathology,…. Hauptthemen laut MEDLINE: Glioblastoma, Machine Learning, Brain Neoplasms, Neovascularization, Pathologic. Die Arbeit nennt 50 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Chongqing Science and Technology Commission, National Major Science and Technology Projects of China.
Abstract (Originalsprache)
Glioblastoma (GBM), a highly vascularized and aggressive primary brain tumor, presents unresolved questions regarding the functional significance of angiogenesis-related genes (ARGs) in disease progression. To systematically investigate this, we employed univariate Cox regression followed by LASSO regression analysis to identify prognosis-associated ARGs. These candidates were subsequently evaluated using six machine learning-derived survival prediction algorithms, with model interpretability achieved through SHapley Additive exPlanations (SHAP) analysis. Our studies revealed that six hub ARGs (BMP2, FSCN1, NET1, AEBP1, SEMA3G, and RAB37) were identified and incorporated into a novel risk stratification model (high and low risk groups). High-risk patients demonstrated significantly poorer overall survival in the CGGA-GBM, GSE43378, and GSE7696 cohorts. Moreover, the high-risk group exhibited an immunosuppressive tumor microenvironment profile (e.g., elevated Treg infiltration, P < 0.0001), increased extracellular matrix stiffness (via mechanosensing markers) and differential drug sensitivity (OncoPredict analysis). Immunofluorescence confirmed co-localization of the hub protein FSCN1 with vascular (CD31⁺), stromal (α-SMA⁺), and mesenchymal (Vimentin⁺) compartments, suggesting its multifunctional role in GBM pathobiology. In summary, our research established the ARG-derived prognostic signature validated across independent GBM cohorts and revealed concomitant immune and mechanical niche dysregulation in high-risk patients. The rationale for combined angiogenesis/stroma/immune modulation strategies was provided, with FSCN1 proposed as the potential therapeutic target.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Pathology, Southwest Hospital, Third Military Medical University (Army Medical University), and Key Laboratory of Tumor Immunopathology, Ministry of Education, and Sichuan-Chongqing Joint Key Laboratory of…
- Department of Emergency, Changhai Hospital, Naval Medical University, Shanghai, China.
Förderung
- National Natural Science Foundation of China
- Chongqing Science and Technology Commission
- National Major Science and Technology Projects of China
Zitieren
APA
Yang, F., Peng, C., Yang, S., Bian, X., & Yao, X. (2026). Deciphering the role of angiogenesis in glioblastoma: Integrative insights from transcriptomic profiling, single-cell sequencing and interpretable machine learning approaches. Pathology - Research and Practice. https://doi.org/10.1016/j.prp.2025.156305
Vancouver
Yang F, Peng C, Yang S, Bian X, Yao X. Deciphering the role of angiogenesis in glioblastoma: Integrative insights from transcriptomic profiling, single-cell sequencing and interpretable machine learning approaches. Pathology - Research and Practice. 2026. doi:10.1016/j.prp.2025.156305
BibTeX
@article{Yang2026,
author = {Yang, Fan and Peng, Chi and Yang, Sisi and Bian, Xiuwu and Yao, Xiaohong},
title = {Deciphering the role of angiogenesis in glioblastoma: Integrative insights from transcriptomic profiling, single-cell sequencing and interpretable machine learning approaches},
journal = {Pathology - Research and Practice},
year = {2026},
doi = {10.1016/j.prp.2025.156305}
}
EUVIMED